C$50.71 close for MFC.TO Manulife Financial (TSX) 27 Jan 2026: market closed as volume tests resistance
MFC.TO stock finished the session at C$50.71 as markets closed on 27 Jan 2026, trading 7,801,933.00 shares on the TSX. The one-day move was -0.18 or -0.35%, leaving the share price within 3% of its 52-week high of C$52.42. Volume was above the 50-day average price trend, putting Manulife Financial Corporation (MFC.TO) among the most active Canadian names today. Investors should watch near-term resistance at the year high and the upcoming earnings date on 11 Feb 2026, which could drive the next leg of activity for this Canadian insurer.
Quick market snapshot for MFC.TO stock
Manulife Financial (MFC.TO) closed at C$50.71 with a market cap of CAD 85,445,842,900.00. The stock traded between C$50.68 and C$51.38 intraday and sits above its 50-day average of C$49.81 and 200-day average of C$44.81.
Trading volume was 7,801,933.00, above the typical daily average of 5,753,008.00, which signals active participation from institutions and retail alike.
Why price moved today — MFC.TO stock drivers
Shares were active after several institutional filings and analyst notes that refreshed targets and ratings. Recent broker target updates include Morgan Stanley C$51.00 and RBC C$52.00, with a MarketBeat consensus near C$51.50 (source).
Investor focus is also on the dividend and capital position; Manulife pays C$1.76 annually, a yield near 3.46%, which supports income demand in the Financial Services sector.
Earnings, dividend and analyst targets for MFC.TO stock
Earnings are scheduled for 11 Feb 2026, which is the next major catalyst for MFC.TO stock (source).
On payouts, Manulife’s annual dividend is C$1.76 and the company reported an EPS of C$3.12 with a trailing PE around 16.25, reflecting a blend of growth and income appeal to Canadian investors.
Technical snapshot for MFC.TO stock
Momentum indicators show a strong near-term trend: RSI 69.10 and ADX 30.55, with MACD histogram 0.12, suggesting bullish bias but near overbought readings. Bollinger bands are tight with upper band C$51.82 and lower band C$48.20, so a break above C$52.42 would extend the rally.
Short-term support sits near the 50-day average C$49.81 and technical volume confirms sustained buying interest today.
Meyka AI rates MFC.TO stock and forecast
Meyka AI rates MFC.TO with a score of 76.50 out of 100 — Grade B+ with a suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a 12-month target of C$55.63, implying an upside of approximately 9.71% versus the current price of C$50.71. Forecasts are model-based projections and not guarantees; they should be used with other research and risk controls. Meyka AI provides this insight as an AI-powered market analysis platform.
Risks and opportunity checklist for MFC.TO stock
Opportunities include steady dividend income, strong free cash flow per share (C$18.06), and exposure to growth in Asia and global asset management. Manulife’s book value per share (C$31.24) and PB ratio near 1.68 support valuation.
Risks include insurance reserve volatility, sensitivity to interest rates and macro insurance cycles, and occasional institutional rebalancing that can add intraday pressure. Monitor upcoming earnings and regulatory headlines for changes to capital and underwriting outlooks.
Final Thoughts
MFC.TO stock closed at C$50.71 on 27 Jan 2026 after an active session that combined above-average volume (7,801,933.00) with modest intraday weakness. Operational metrics remain solid: EPS C$3.12, trailing PE 16.25, and strong free cash flow per share (C$18.06). Analyst coverage skewed positive with consensus targets around C$51.50 and several buy/outperform notes from Canadian brokers. Meyka AI’s internal model projects C$55.63 over the next 12 months, an implied upside of 9.71% versus today’s close; this figure reflects earnings momentum and dividend support but is not a guarantee. For most-active traders, the near-term technical focus is a break above the C$52.42 year high or a fade back toward the 50-day average C$49.81. Long-term investors should weigh Manulife’s diversified insurance and asset-management exposure, dividend yield (3.46%) and capital metrics against underwriting and interest-rate risks. Use upcoming earnings on 11 Feb 2026 and the Meyka AI grade as inputs in portfolio decisions, and combine them with your own risk tolerance and time horizon.
FAQs
What is the current price and dividend yield for MFC.TO stock?
MFC.TO stock closed at C$50.71 on 27 Jan 2026. The annual dividend is C$1.76, yielding about 3.46% at the current price. Check payout ratio and cash flow when assessing income reliability.
When is Manulife’s next earnings date and why does it matter for MFC.TO stock?
Manulife’s next earnings announcement is scheduled for 11 Feb 2026. Earnings drive short-term volatility and update guidance, reserve assumptions, and performance in insurance and asset management, so expect higher trading activity around the release.
How does Meyka AI grade MFC.TO stock and what does it mean?
Meyka AI rates MFC.TO with a score of 76.50 (Grade B+, suggestion: BUY). The grade blends benchmark, sector, financial growth, key metrics, forecasts, and analyst consensus. It’s informational and not investment advice.
What price target and upside does the Meyka AI forecast show for MFC.TO stock?
Meyka AI’s forecast model projects a 12-month target of C$55.63 for MFC.TO stock, implying an upside of approximately 9.71% versus the current C$50.71 close. Forecasts are model-based and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
